Filing Flows › Opko Health (OPK) › Stock forecast & fair value
Opko Health (OPK) stock forecast and price target
Opko Health (OPK) trades at $1.73. 5 analysts' median price target is $3.00 (+73%), from $2.25 to $8.50.
Opko Health's latest quarter
Opko Health, Q3 2026: revenue $65.4M (+16% year over year), operating margin -48.0%, net loss $53.5M, operating cash flow −$36.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for OPK stock?
The median of 5 analysts' 12-month targets is $3.00, +73% from $1.73; the range is $2.25 to $8.50. The average rating is buy.
Does Opko Health usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is OPK stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.